Medley Management Inc (MDLY) Fundamental Analysis & Valuation

NYSE:MDLY

Current stock price

5.88
+0.1 (+1.73%)
Last:

This MDLY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. MDLY Profitability Analysis

1.1 Basic Checks

  • In the past year MDLY has reported negative net income.

1.2 Ratios

Industry RankSector Rank
ROA -7.49%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -14.15%
PM (TTM) -8.01%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. MDLY Health Analysis

2.1 Basic Checks

  • There is no outstanding debt for MDLY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

  • MDLY has an Altman-Z score of -3.68. This is a bad value and indicates that MDLY is not financially healthy and even has some risk of bankruptcy.
  • A Debt/Equity ratio of -0.97 indicates that MDLY is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity -0.97
Debt/FCF N/A
Altman-Z -3.68
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

  • A Current Ratio of 0.14 indicates that MDLY may have some problems paying its short term obligations.
  • A Quick Ratio of 0.14 indicates that MDLY may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.14
Quick Ratio 0.14

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. MDLY Growth Analysis

3.1 Past

  • MDLY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.00%, which is quite impressive.
  • Looking at the last year, MDLY shows a very negative growth in Revenue. The Revenue has decreased by -31.92% in the last year.
  • The Revenue for MDLY have been decreasing by -13.18% on average. This is quite bad
EPS 1Y (TTM)29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.25%
Revenue 1Y (TTM)-31.92%
Revenue growth 3Y-20.04%
Revenue growth 5Y-13.18%
Sales Q2Q%-20.43%

3.2 Future

  • MDLY is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -3.61% yearly.
  • The Revenue is expected to decrease by -31.10% on average over the next years. This is quite bad
EPS Next Y0%
EPS Next 2Y-3.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.41%
Revenue Next 2Y-31.1%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MDLY Yearly Revenue VS EstimatesMDLY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M
MDLY Yearly EPS VS EstimatesMDLY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 0 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

0

4. MDLY Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MDLY. In the last year negative earnings were reported.
  • Also next year MDLY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MDLY Price Earnings VS Forward Price EarningsMDLY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -57.79
MDLY Per share dataMDLY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -50 -100 -150

4.3 Compensation for Growth

  • MDLY's earnings are expected to decrease with -3.61% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.61%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. MDLY Dividend Analysis

5.1 Amount

  • MDLY has a Yearly Dividend Yield of 11.90%, which is a nice return.
  • The stock price of MDLY dropped by -29.50% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • Compared to an average S&P500 Dividend Yield of 1.80, MDLY pays a better dividend.
Industry RankSector Rank
Dividend Yield 11.9%

5.2 History

  • The dividend of MDLY decreases each year by -34.93%.
  • MDLY has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-34.93%
Div Incr YearsN/A
Div Non Decr YearsN/A
MDLY Yearly Dividends per shareMDLY Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2 4 6

5.3 Sustainability

  • The Dividend Rate of MDLY has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP0%
EPS Next 2Y-3.61%
EPS Next 3YN/A

More info and screens

Find the best dividend stocksShow peers with best dividend

MDLY Fundamentals: All Metrics, Ratios and Statistics

Medley Management Inc

NYSE:MDLY (7/6/2021, 8:04:00 PM)

5.88

+0.1 (+1.73%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0%
Inst Owner Change0%
Ins Owners403.16%
Ins Owner Change0%
Market Cap3.94M
Revenue(TTM)33.25M
Net Income(TTM)-2.66M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 11.9%
Yearly Dividend0.7
Dividend Growth(5Y)-34.93%
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.12
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA -57.79
EPS(TTM)-4.26
EYN/A
EPS(NY)-0.17
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS49.63
BVpS-199.51
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -7.49%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -14.15%
PM (TTM) -8.01%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score0
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity -0.97
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.14
Quick Ratio 0.14
Altman-Z -3.68
F-Score0
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.25%
EPS Next Y0%
EPS Next 2Y-3.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.92%
Revenue growth 3Y-20.04%
Revenue growth 5Y-13.18%
Sales Q2Q%-20.43%
Revenue Next Year-11.41%
Revenue Next 2Y-31.1%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Medley Management Inc / MDLY Fundamental Analysis FAQ

What is the ChartMill fundamental rating of Medley Management Inc (MDLY) stock?

ChartMill assigns a fundamental rating of 1 / 10 to MDLY.


What is the valuation status for MDLY stock?

ChartMill assigns a valuation rating of 0 / 10 to Medley Management Inc (MDLY). This can be considered as Overvalued.


What is the profitability of MDLY stock?

Medley Management Inc (MDLY) has a profitability rating of 0 / 10.


Can you provide the dividend sustainability for MDLY stock?

The dividend rating of Medley Management Inc (MDLY) is 6 / 10 and the dividend payout ratio is 0%.